Vela Diagnostics Vela Diagnostics, National Cancer Center of Singapore to Develop CDx for EGFR-TKI Therapies Vela Diagnostics and NCCS will evaluate the efficacy of the assay in a clinical trial to test the response of patients to EGFR-TKI therapies. Vela Diagnostics Receives Second FDA Emergency Use Authorization for SARS-CoV-2 Molecular Test The second EUA for a test that targets the ORF1a and N genes is for an automated version of a manual test that had been granted EUA in August. Vela Diagnostics, Capstone Healthcare Get FDA Emergency Use Authorization for Coronavirus Tests The Vela and Capstone tests are both PCR-based and designed to detect their viral RNA targets in nasopharyngeal and oropharyngeal swab specimens. Vela Diagnostics Automated Coronavirus Test Gets CE-IVD Mark Vela Diagnostics said that the RT-PCR-based test has also received provisional authorization from the Health Sciences Authority in Singapore. Vela Diagnostics, JN Medsys Get CE-IVD Marks for Coronavirus Tests Vela anticipates CE-IVD marking for an automated version of its test, and JN Medsys has received authorization for its test in Singapore and the Philippines. Apr 20, 2020 Vela Diagnostics Awarded BARDA Funding for COVID-19 Test Apr 16, 2020 Vela Diagnostics Coronavirus RT-PCR Test Provisionally Authorized by Singapore Regulator Feb 7, 2020 In Brief This Week: LineaRx, OncoCyte, Vela Diagnostics, CosmosID, More Nov 5, 2019 FDA Authorizes Marketing of Vela Diagnostics NGS-Based HIV-1 Drug Resistance Mutation Test Mar 26, 2019 Vela Diagnostics Submits NGS HIV Genotyping, Drug Resistance Assay to FDA Jul 23, 2018 Vela Diagnostics Accelerates Entry Into US Microbiology Market With Great Basin Buy Premium Jun 25, 2018 Vela Diagnostics Buys Great Basin Scientific Aug 18, 2017 Great Basin in Default of Senior Notes for $18.3M Jul 13, 2017 Great Basin Receives FDA Clearance for Stool Bacterial Pathogens Panel Jun 22, 2017 Great Basin Closes $2.1M Offering Jun 20, 2017 Great Basin Scientific Prices $2.7M Securities Offering May 23, 2017 Great Basin Plans to Raise $3.5M May 22, 2017 Great Basin Reports 14 Percent Revenue Growth in Q1 May 16, 2017 Great Basin Whooping Cough Test Gets CE Marking May 12, 2017 In Brief This Week: Alere, Fulgent Diagnostics, Trovagene, Great Basin, and More Apr 12, 2017 Great Basin Gets CE Mark for Stool Pathogens Panel Apr 10, 2017 Great Basin Restructures Convertible Securities, Gaining Access to Cash Apr 3, 2017 Great Basin Whooping Cough MDx Clears FDA Mar 22, 2017 Great Basin Q4 Revenues Rise 39 Percent Feb 14, 2017 Great Basin Files to Raise $10M Load More Breaking News Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel Type 1 Diabetes GWAS, Fine-Mapping Leads to New Genetic Loci, Potential Drug Targets LSU Health Sciences Center Wins $2.4M to Lead SARS-CoV-2 Variant Sequencing Program NanoString Technologies, Parker Institute for Cancer Immunotherapy Partner on Cell Therapy Project BGI Americas Collaborating With Champions Oncology on Proteomic Cancer Research Personal Genome Diagnostics Inks Cancer Genomic Profiling Deal with Duke University Health System The Scan Missed Early Cases A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports. Limited Journal Editor Diversity A survey finds low diversity among scientific and medical journal editors, according to The Scientist. How Much of a Threat? Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned. PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.